Caribou Biosciences Inc (NASDAQ:CRBU) shares, rose in value, with the stock price down by -0.51% to the previous day’s close as strong demand from buyers drove the stock to $1.96.
Actively observing the price movement in the last trading, the stock closed the session at $1.97, falling within a range of $1.865 and $2.0. The value of beta (5-year monthly) was 2.274. Referring to stock’s 52-week performance, its high was $8.33, and the low was $1.50. On the whole, CRBU has fluctuated by 10.11% over the past month.
With the market capitalization of Caribou Biosciences Inc currently standing at about $177.11 million, investors are eagerly awaiting this quarter’s results, scheduled for in December.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 3.1M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRBU’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CRBU currently trading nearly 2.67% and 0.11% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.22, while the 7-day volatility ratio is showing 9.32% which for the 30-day chart, stands at 6.36%. Furthermore, Caribou Biosciences Inc (CRBU)’s beta value is 2.27, and its average true range (ATR) is 0.13.
A comparison of Caribou Biosciences Inc (CRBU) with its peers suggests the former has fared considerably weaker in the market. CRBU showed an intraday change of -0.51% in last session, and over the past year, it shrunk by -46.01%%.
Data on historical trading for Caribou Biosciences Inc (NASDAQ:CRBU) indicates that the trading volumes over the past 10 days have averaged 1.05 and over the past 3 months, they’ve averaged 935.40K. According to company’s latest data on outstanding shares, there are 88.45 million shares outstanding.
Nearly 11.67% of Caribou Biosciences Inc’s shares belong to company insiders and institutional investors own 60.05% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.51 million shares as on 2024-10-15, resulting in a short ratio of 14.05. According to the data, the short interest in Caribou Biosciences Inc (CRBU) stood at 1335.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 11.63 million. The stock has fallen by -65.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRBU stock heading into the next quarter.
